Literature DB >> 10691854

Prevalence of the post-thrombotic syndrome in young women with previous venous thromboembolism.

M D McColl1, J Ellison, I A Greer, R C Tait, I D Walker.   

Abstract

The prevalence of mild, moderate and severe post-thrombotic syndrome (PTS) among 43 young women with a previous single episode of deep vein thrombosis (DVT) was 67%, 7% and 0% respectively. Subjects were assessed at a mean 51 months after the event. Moderate PTS was more common in women with recurrent (n = 9) DVT (44%, P < 0.001). Chronic venous insufficiency, assessed by light reflection rheography (LRR), was significantly (P < 0.05) more prevalent in women with single previous DVT (n = 40), recurrent DVT (n = 9) and isolated pulmonary embolism (PE) (n = 19) compared with healthy age-matched controls (odds ratios 10.9, 52.4 and 3.8 respectively). LRR findings correlated with moderate, but not mild, PTS. There was no correlation between development of PTS and body mass index.

Entities:  

Mesh:

Year:  2000        PMID: 10691854     DOI: 10.1046/j.1365-2141.2000.01877.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  11 in total

1.  VTE, thrombophilia, antithrombotic therapy, and pregnancy: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.

Authors:  Shannon M Bates; Ian A Greer; Saskia Middeldorp; David L Veenstra; Anne-Marie Prabulos; Per Olav Vandvik
Journal:  Chest       Date:  2012-02       Impact factor: 9.410

Review 2.  The post-thrombotic syndrome: the forgotten morbidity of deep venous thrombosis.

Authors:  Susan R Kahn
Journal:  J Thromb Thrombolysis       Date:  2006-02       Impact factor: 2.300

3.  Large Uterine Fibromyoma: Association with DVT of Pelvic veins and Pulmonary Thromboembolism. A Series of Four Such Rare Cases.

Authors:  Tibrewal Anuradha; Gupta Suchi; Kamineni Vasundhara
Journal:  J Obstet Gynaecol India       Date:  2013-04-12

4.  Women's values and preferences for thromboprophylaxis during pregnancy: a comparison of direct-choice and decision analysis using patient specific utilities.

Authors:  Mark H Eckman; Pablo Alonso-Coello; Gordon H Guyatt; Shanil Ebrahim; Kari A O Tikkinen; Luciane Cruz Lopes; Ignacio Neumann; Sarah D McDonald; Yuqing Zhang; Qi Zhou; Elie A Akl; Ann Flem Jacobsen; Amparo Santamaría; Joyce Maria Annichino-Bizzacchi; Wael Bitar; Per Morten Sandset; Shannon M Bates
Journal:  Thromb Res       Date:  2015-05-22       Impact factor: 3.944

5.  American Society of Hematology 2018 guidelines for management of venous thromboembolism: venous thromboembolism in the context of pregnancy.

Authors:  Shannon M Bates; Anita Rajasekhar; Saskia Middeldorp; Claire McLintock; Marc A Rodger; Andra H James; Sara R Vazquez; Ian A Greer; John J Riva; Meha Bhatt; Nicole Schwab; Danielle Barrett; Andrea LaHaye; Bram Rochwerg
Journal:  Blood Adv       Date:  2018-11-27

6.  Hereditary risk factors for thrombophilia and probability of venous thromboembolism during pregnancy and the puerperium.

Authors:  Andrea Gerhardt; Rüdiger E Scharf; Ian A Greer; Rainer B Zotz
Journal:  Blood       Date:  2016-09-09       Impact factor: 22.113

Review 7.  Anticoagulants in pregnancy.

Authors:  Ian A Greer
Journal:  J Thromb Thrombolysis       Date:  2006-02       Impact factor: 2.300

8.  Evaluating patient values and preferences for thromboprophylaxis decision making during pregnancy: a study protocol.

Authors:  Pablo Alonso-Coello; Shanil Ebrahim; Gordon H Guyatt; Kari A O Tikkinen; Mark H Eckman; Ignacio Neumann; Sarah D McDonald; Elie A Akl; Shannon M Bates
Journal:  BMC Pregnancy Childbirth       Date:  2012-05-30       Impact factor: 3.007

9.  Obstetric thromboprophylaxis: the Swedish guidelines.

Authors:  Pelle G Lindqvist; Margareta Hellgren
Journal:  Adv Hematol       Date:  2011-11-22

10.  Guidance for the treatment and prevention of obstetric-associated venous thromboembolism.

Authors:  Shannon M Bates; Saskia Middeldorp; Marc Rodger; Andra H James; Ian Greer
Journal:  J Thromb Thrombolysis       Date:  2016-01       Impact factor: 2.300

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.